New York University - College of Dentistry
Home The College Research Academic Programs Library/Resources Continuing Education Community Outreach International Programs
Click to View Virtual Tour




 > News

News

BLUESTONE CENTER FEATURED ON WABC-TV’S “NEW YORK VIEWPOINT”

Dr. Brian Schmidt
July 03, 2011 - Dr. Brian Schmidt and Dr. Stephen Ross represented NYU College of Dentistry’s Bluestone Center for Clinical Research on New York Viewpoint, a Sunday morning talk show hosted by Eyewitness News anchor Lori Stokes. The round table discussion highlighted the Bluestone Center’s biomedical research focusing on symptoms related to cancer pain, depression and anxiety.

Brian Schmidt, DDS, MD, PhD, and NYU Professor of Oral & Maxillofacial Surgery and Director of the Bluestone Center, discussed the importance of clinical research and his particular interest in studying symptoms and treatment related to cancer. As Schmidt explained, “research has been so focused on cure that we forget about those patients who are suffering in the final months or years of their lives.” With cancers becoming more treatable, patients are living longer and living with the symptoms. We are now discovering from genomics how to identify early on whether patients are going to have problems related to the cancer treatment.”

Stephen Ross, MD and Director and Principal Investigator of the NYU Psilocybin Cancer Anxiety Study, discussed his ground-breaking research with psilocybin, an active ingredient in a certain kind of mushroom. Psilocybin has been used for centuries by spiritual, religious, and cultural groups for transformation rites and healing related activity. “With psilocybin assisted existentially-oriented psychotherapy for distress associated with cancer, we have seen acute resolution or reduction of death anxiety, as well as decreased pain and depression.Patients are becoming more authentic in their lives and tackling unresolved conflicts.”

The Bluestone Center employs a variety of recruitment methods for their clinical trials, including direct advertisement and outreach to oncologists. Approximately 3% of cancer patients enroll in clinical trials. Clinical trials are the “gold standard” in making advances in drug therapies, new devices, and ways to diagnose cancer earlier. While clinical trials are critical for improving care, recruitment remains our greatest challenge.

Each week, over 36,000 households tune in to watch "New York Viewpoint.” The programs highlight the community and cultural efforts that enrich the quality of life in NYC. New York Viewpoint airs at 5:30 a.m. on Sunday mornings.

To view this segment, go to: New York Viewpoint/7online.com
Click on: VIDEO: NY VIEWPOINT - July 3, 2011 Part 2

View All News Archive Media Contacts
Share on Facebook